Lord, C. et al. Autism spectrum disorder. Lancet 392(10146), 508–520 (2018).
Iossifov, I. et al. The contribution of de novo coding mutations to autism spectrum disorder. Nature 515(7526), 216–221 (2014).
Yuen, R. et al. Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder. Nat. Neurosci. 20(4), 602–611 (2017).
Stessman, H. A. et al. Targeted sequencing identifies 91 neurodevelopmental-disorder risk genes with autism and developmental-disability biases. Nat. Genet. 49(4), 515–526 (2017).
Satterstrom, F. K. et al. Large-scale exome sequencing study implicates both developmental and functional changes in the neurobiology of autism. Cell 180(3), 568-584 e23 (2020).
Willsey, A. J. et al. Coexpression networks implicate human midfetal deep cortical projection neurons in the pathogenesis of autism. Cell 155(5), 997–1007 (2013).
Parikshak, N. N. et al. Integrative functional genomic analyses implicate specific molecular pathways and circuits in autism. Cell 155(5), 1008–1021 (2013).
De Rubeis, S. et al. Synaptic, transcriptional and chromatin genes disrupted in autism. Nature 515(7526), 209–215 (2014).
O’Roak, B. J. et al. Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders. Science 338(6114), 1619–1622 (2012).
van Bon, B. W. et al. Disruptive de novo mutations of DYRK1A lead to a syndromic form of autism and ID. Mol. Psychiatry 21(1), 126–132 (2016).
Evers, J. M. et al. Structural analysis of pathogenic mutations in the DYRK1A gene in patients with developmental disorders. Hum. Mol. Genet. 26(3), 519–526 (2017).
Arranz, J. et al. Impaired development of neocortical circuits contributes to the neurological alterations in DYRK1A haploinsufficiency syndrome. Neurobiol. Dis. 127, 210–222 (2019).
Moller, R. S. et al. Truncation of the Down syndrome candidate gene DYRK1A in two unrelated patients with microcephaly. Am. J. Hum. Genet. 82(5), 1165–1170 (2008).
van Bon, B. W. et al. Intragenic deletion in DYRK1A leads to mental retardation and primary microcephaly. Clin. Genet. 79(3), 296–299 (2011).
Courcet, J. B. et al. The DYRK1A gene is a cause of syndromic intellectual disability with severe microcephaly and epilepsy. J. Med. Genet. 49(12), 731–736 (2012).
Ji, J. et al. DYRK1A haploinsufficiency causes a new recognizable syndrome with microcephaly, intellectual disability, speech impairment, and distinct facies. Eur. J. Hum. Genet. 23(11), 1473–1481 (2015).
Earl, R. K. et al. Clinical phenotype of ASD-associated DYRK1A haploinsufficiency. Mol. Autism 8, 54 (2017).
Fenster, R. et al. Characterization of phenotypic range in DYRK1A haploinsufficiency syndrome using standardized behavioral measures. Am. J. Med. Genet. A 5, 22 (2022).
Hanly, C. et al. Description of neurodevelopmental phenotypes associated with 10 genetic neurodevelopmental disorders: A scoping review. Clin. Genet. 99(3), 335–346 (2021).
Becker, W. & Sippl, W. Activation, regulation, and inhibition of DYRK1A. FEBS J. 278(2), 246–256 (2011).
Aranda, S., Laguna, A. & de la Luna, S. DYRK family of protein kinases: Evolutionary relationships, biochemical properties, and functional roles. FASEB J. 25(2), 449–462 (2011).
Arbones, M. L. et al. DYRK1A and cognition: A lifelong relationship. Pharmacol. Ther. 194, 199–221 (2019).
Tejedor, F. J. & Hammerle, B. MNB/DYRK1A as a multiple regulator of neuronal development. FEBS J. 278(2), 223–235 (2011).
Fotaki, V. et al. Dyrk1A haploinsufficiency affects viability and causes developmental delay and abnormal brain morphology in mice. Mol. Cell Biol. 22(18), 6636–6647 (2002).
Arque, G. et al. Impaired spatial learning strategies and novel object recognition in mice haploinsufficient for the dual specificity tyrosine-regulated kinase-1A (Dyrk1A). PLoS ONE 3(7), e2575 (2008).
Raveau, M. et al. DYRK1A-haploinsufficiency in mice causes autistic-like features and febrile seizures. Neurobiol. Dis. 110, 180–191 (2018).
Najas, S. et al. DYRK1A-mediated cyclin D1 degradation in neural stem cells contributes to the neurogenic cortical defects in down syndrome. EBioMedicine 2(2), 120–134 (2015).
Benavides-Piccione, R. et al. Alterations in the phenotype of neocortical pyramidal cells in the Dyrk1A+/− mouse. Neurobiol. Dis. 20(1), 115–122 (2005).
Allen, N. J. & Lyons, D. A. Glia as architects of central nervous system formation and function. Science 362(6411), 181–185 (2018).
Zeidan-Chulia, F. et al. The glial perspective of autism spectrum disorders. Neurosci. Biobehav. Rev. 38, 160–172 (2014).
Sloan, S. A. & Barres, B. A. Mechanisms of astrocyte development and their contributions to neurodevelopmental disorders. Curr. Opin. Neurobiol. 27, 75–81 (2014).
Phan, B. N. et al. A myelin-related transcriptomic profile is shared by Pitt-Hopkins syndrome models and human autism spectrum disorder. Nat. Neurosci. 23(3), 375–385 (2020).
Miller, F. D. & Gauthier, A. S. Timing is everything: Making neurons versus glia in the developing cortex. Neuron 54(3), 357–369 (2007).
Kriegstein, A. & Alvarez-Buylla, A. The glial nature of embryonic and adult neural stem cells. Annu. Rev. Neurosci. 32, 149–184 (2009).
Bergles, D. E. & Richardson, W. D. Oligodendrocyte Development and Plasticity. Cold Spring Harb Perspect. Biol. 8(2), a020453 (2015).
Guedj, F. et al. DYRK1A: A master regulatory protein controlling brain growth. Neurobiol. Dis. 46(1), 190–203 (2012).
Ge, W. P. et al. Local generation of glia is a major astrocyte source in postnatal cortex. Nature 484(7394), 376–380 (2012).
Fernandez-Martinez, J. et al. Attenuation of Notch signalling by the Down-syndrome-associated kinase DYRK1A. J. Cell Sci. 122(Pt 10), 1574–1583 (2009).
Kurabayashi, N., Nguyen, M. D. & Sanada, K. DYRK1A overexpression enhances STAT activity and astrogliogenesis in a Down syndrome mouse model. EMBO Rep. 16(11), 1548–1562 (2015).
Hutton, S. R. & Pevny, L. H. SOX2 expression levels distinguish between neural progenitor populations of the developing dorsal telencephalon. Dev. Biol. 352(1), 40–47 (2011).
Sofroniew, M. V. & Vinters, H. V. Astrocytes: biology and pathology. Acta Neuropathol 119(1), 7–35 (2010).
Sun, W. et al. SOX9 is an astrocyte-specific nuclear marker in the adult brain outside the neurogenic regions. J. Neurosci. 37(17), 4493–4507 (2017).
Ito, D. et al. Microglia-specific localisation of a novel calcium binding protein, Iba1. Brain Res. Mol. Brain Res. 57(1), 1–9 (1998).
Kessaris, N. et al. Competing waves of oligodendrocytes in the forebrain and postnatal elimination of an embryonic lineage. Nat. Neurosci. 9(2), 173–179 (2006).
Polioudakis, D. et al. A single-cell transcriptomic atlas of human neocortical development during mid-gestation. Neuron 103(5), 785-801 e8 (2019).
Zhang, Y. et al. Purification and characterization of progenitor and mature human astrocytes reveals transcriptional and functional differences with mouse. Neuron 89(1), 37–53 (2016).
Pringle, N. P. & Richardson, W. D. A singularity of PDGF alpha-receptor expression in the dorsoventral axis of the neural tube may define the origin of the oligodendrocyte lineage. Development 117(2), 525–533 (1993).
Sturrock, R. R. Myelination of the mouse corpus callosum. Neuropathol. Appl. Neurobiol. 6(6), 415–420 (1980).
Snaidero, N. & Simons, M. Myelination at a glance. J. Cell Sci. 127(Pt 14), 2999–3004 (2014).
Simons, M. & Trajkovic, K. Neuron-glia communication in the control of oligodendrocyte function and myelin biogenesis. J. Cell Sci. 119(Pt 21), 4381–4389 (2006).
Stassart, R. M. et al. The axon-myelin unit in development and degenerative disease. Front. Neurosci. 12, 467 (2018).
Caldwell, J. H. et al. Sodium channel Na(v)1.6 is localized at nodes of ranvier, dendrites, and synapses. Proc. Natl. Acad. Sci. U S A 97(10), 5616–20 (2000).
Einheber, S. et al. The axonal membrane protein Caspr, a homologue of neurexin IV, is a component of the septate-like paranodal junctions that assemble during myelination. J. Cell Biol. 139(6), 1495–1506 (1997).
Xin, W. & Chan, J. R. Myelin plasticity: Sculpting circuits in learning and memory. Nat. Rev. Neurosci. 21(12), 682–694 (2020).
Zdaniuk, G. et al. Astroglia disturbances during development of the central nervous system in fetuses with Down’s syndrome. Folia Neuropathol. 49(2), 109–114 (2011).
Duchon, A. et al. Identification of the translocation breakpoints in the Ts65Dn and Ts1Cje mouse lines: Relevance for modeling Down syndrome. Mamm. Genome 22(11–12), 674–684 (2011).
Perez-Catalan, N. A., Doe, C. Q. & Ackerman, S. D. The role of astrocyte-mediated plasticity in neural circuit development and function. Neural Dev. 16(1), 1 (2021).
Baldwin, K. T. & Eroglu, C. Molecular mechanisms of astrocyte-induced synaptogenesis. Curr. Opin. Neurobiol. 45, 113–120 (2017).
Brault, V. et al. Dyrk1a gene dosage in glutamatergic neurons has key effects in cognitive deficits observed in mouse models of MRD7 and Down syndrome. PLoS Genet. 17(9), e1009777 (2021).
Grau, C. et al. DYRK1A-mediated phosphorylation of GluN2A at Ser(1048) regulates the surface expression and channel activity of GluN1/GluN2A receptors. Front. Cell Neurosci. 8, 331 (2014).
Araque, A. & Perea, G. Glial modulation of synaptic transmission in culture. Glia 47(3), 241–248 (2004).
Dallerac, G., Zapata, J. & Rouach, N. Versatile control of synaptic circuits by astrocytes: where, when and how?. Nat. Rev. Neurosci. 19(12), 729–743 (2018).
Marti, E. et al. Dyrk1A expression pattern supports specific roles of this kinase in the adult central nervous system. Brain Res. 964(2), 250–263 (2003).
Blanco-Suarez, E., Caldwell, A. L. & Allen, N. J. Role of astrocyte-synapse interactions in CNS disorders. J. Physiol. 595(6), 1903–1916 (2017).
De Leon, R. N. S., Bragg-Gonzalo, L. & Nieto, M. Development and plasticity of the corpus callosum. Development 147(18), 555 (2020).
Just, M. A. et al. Functional and anatomical cortical underconnectivity in autism: Evidence from an FMRI study of an executive function task and corpus callosum morphometry. Cereb Cortex 17(4), 951–961 (2007).
Fenlon, L. R. & Richards, L. J. Contralateral targeting of the corpus callosum in normal and pathological brain function. Trends Neurosci. 38(5), 264–272 (2015).
Harting, I. et al. Abnormal myelination in Angelman syndrome. Eur. J. Paediatr. Neurol. 13(3), 271–276 (2009).
Kortum, F. et al. The core FOXG1 syndrome phenotype consists of postnatal microcephaly, severe mental retardation, absent language, dyskinesia, and corpus callosum hypogenesis. J. Med. Genet. 48(6), 396–406 (2011).
Zhao, C. et al. Dual requirement of CHD8 for chromatin landscape establishment and histone methyltransferase recruitment to promote CNS myelination and repair. Dev. Cell 45(6), 753-768 e8 (2018).
Kawamura, A. et al. Oligodendrocyte dysfunction due to Chd8 mutation gives rise to behavioral deficits in mice. Hum. Mol. Genet. 29(8), 1274–1291 (2020).
Durand, B. & Raff, M. A cell-intrinsic timer that operates during oligodendrocyte development. BioEssays 22(1), 64–71 (2000).
Tomassy, G. S., Dershowitz, L. B. & Arlotta, P. Diversity matters: A revised guide to myelination. Trends Cell Biol. 26(2), 135–147 (2016).
Cleveland, D. W. Neuronal growth and death: Order and disorder in the axoplasm. Cell 84(5), 663–666 (1996).
Kevenaar, J. T. & Hoogenraad, C. C. The axonal cytoskeleton: From organization to function. Front. Mol. Neurosci. 8, 44 (2015).
Kirkcaldie, M. T. K. & Dwyer, S. T. The third wave: Intermediate filaments in the maturing nervous system. Mol. Cell Neurosci. 84, 68–76 (2017).
Nelson, A. D. & Jenkins, P. M. Axonal membranes and their domains: Assembly and function of the axon initial segment and node of Ranvier. Front. Cell Neurosci. 11, 136 (2017).
Rasband, M. N. & Peles, E. Mechanisms of node of Ranvier assembly. Nat. Rev. Neurosci. 22, 7–20 (2020).
Souchet, B. et al. Excitation/inhibition balance and learning are modified by Dyrk1a gene dosage. Neurobiol. Dis. 69, 65–75 (2014).
Olmos-Serrano, J. L. et al. Down syndrome developmental brain transcriptome reveals defective oligodendrocyte differentiation and myelination. Neuron 89(6), 1208–1222 (2016).
Barak, B. et al. Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioral and myelin alterations rescuable by a remyelinating drug. Nat. Neurosci. 22(5), 700–708 (2019).
Kato, D. & Wake, H. Myelin plasticity modulates neural circuitry required for learning and behavior. Neurosci. Res. 167, 11–16 (2021).
Inoue, K. Pelizaeus-merzbacher disease: Molecular and cellular pathologies and associated phenotypes. Adv. Exp. Med. Biol. 1190, 201–216 (2019).
Miller, D. J. et al. Prolonged myelination in human neocortical evolution. Proc. Natl. Acad. Sci. U S A 109(41), 16480–16485 (2012).
Paxinos, G. & Franklin, K. B. J. The Mouse Brain in Stereotaxic Coordinates 2nd edn. (Elsevier, 2008).
Fernandez, E., Cuenca, N. & De Juan, J. A useful programme in BASIC for axonal morphometry with introduction of new cytoskeletal parameters. J. Neurosci. Methods. 39(3), 271–289 (1991).